Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AML
Trial details
- Registry ID
- NCT02781883
- Drugs studied
- BP1001 in combination with Ventoclax plus decitabine, BP1001 plus decitabine
TrialRedline tracks 1 clinical trial sponsored by Bio-Path Holdings, Inc.: 1 Phase 2.
Company identity has not yet been verified
| Trial | Drugs studied | Status | Primary completion |
|---|---|---|---|
| Clinical Trial of BP1001 in Combination With With Venetoclax Plus Decitabine in AMLNCT02781883 | BP1001 in combination with Ventoclax plus decitabine, BP1001 plus decitabine | Recruiting | 2027-12Estimated |
Names as written in the registry records.